✦ LIBER ✦
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein
✍ Scribed by Bates, John T.; Keefer, Christopher J.; Slaughter, James C.; Kulp, Daniel W.; Schief, William R.; Crowe, James E.
- Book ID
- 123558886
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 589 KB
- Volume
- 454-455
- Category
- Article
- ISSN
- 0042-6822
No coin nor oath required. For personal study only.